Date published: 2025-11-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Exendin-4 (CAS 141758-74-9)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
Exendin-4 is also known as Exenatide.
Application:
Exendin-4 is a 39 amino acid polypeptide, incretin mimetic, GLP-1R agonist, and insulinotropic agent.
CAS Number:
141758-74-9
Purity:
≥97%
Molecular Weight:
4186.57
Molecular Formula:
C184H282N50O60S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Exendin-4 is a 39 amino acid polypeptide and incretin mimetic involved in glucose-dependent enhancement of insulin secretion. It also promotes reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying, and reduction of food intake, often with body weight reduction or blunting of weight gain. Exendin-4 is a GLP-1R agonist, has a long half-life, and performs as an insulinotropic agent. It was originally sourced from the Gila monster lizard, Heloderma suspectum.


Exendin-4 (CAS 141758-74-9) References

  1. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.  |  Xu, G., et al. 1999. Diabetes. 48: 2270-6. PMID: 10580413
  2. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.  |  Eng, J., et al. 1992. J Biol Chem. 267: 7402-5. PMID: 1313797
  3. Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes.  |  Komsuoglu Celikyurt, I., et al. 2014. Med Sci Monit Basic Res. 20: 112-7. PMID: 25076419
  4. Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer's disease.  |  An, J., et al. 2019. Behav Brain Res. 370: 111932. PMID: 31082410
  5. Exenatide Reduces Graft Injury in a Rat Transplantation Model Using Kidneys Donated after Cardiac Death.  |  Hua Yang, ., et al. 2019. Transplant Proc. 51: 2116-2123. PMID: 31303407
  6. Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon.  |  Li, Y., et al. 2019. Sci Rep. 9: 17208. PMID: 31748513
  7. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.  |  Saad, ZA., et al. 2020. Life Sci. 253: 117725. PMID: 32348835
  8. Exenatide improves random-pattern skin flap survival via TFE3 mediated autophagy augment.  |  Li, J., et al. 2021. J Cell Physiol. 236: 3641-3659. PMID: 33044023
  9. Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.  |  Liu, Y., et al. 2021. Front Endocrinol (Lausanne). 12: 663039. PMID: 33953700
  10. Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m6A methylation.  |  Zhou, S., et al. 2022. Eur J Pharmacol. 924: 174960. PMID: 35436474
  11. Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC).  |  Twarog, C., et al. 2022. Int J Pharm. 626: 122131. PMID: 36028084
  12. Exenatide increases CTRP3 gene expression in adipose cells by inhibiting adipogenesis and induces apoptosis.  |  Koldemir Gündüz, M., et al. 2022. Toxicol In Vitro. 85: 105479. PMID: 36152787
  13. Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice.  |  Xu, Q., et al. 2022. Mol Med. 28: 144. PMID: 36463128

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Exendin-4, 500 µg

sc-474611
500 µg
$143.00

Exendin-4, 1 mg

sc-474611A
1 mg
$194.00